Researchers conducted the study for determining prognostic factors and survival patterns for different treatment modalities for the nasal cavity (NC) and paranasal sinus (PS) mucosal melanoma (MM).
Scientific Publications
Impact of novel systemic therapies on the first-year costs of care for melanoma among Medicare beneficiaries
Because of the adoption of immune checkpoint inhibitor and targeted therapies since 2011, the therapeutic landscape of melanoma has changed dramatically.
Biomarker May Predict Treatment Outcome in Advanced Melanoma
Among patients receiving targeted therapy for advanced melanoma, BRAF V600-mutant cell-free circulating tumor DNA (ctDNA) measurements potentially could predict clinical outcome, according to a study published online Feb
Structured Surveillance Program May Provide Earlier Detection of Melanoma
A study evaluated the feasibility and success of a structured surveillance program at skin clinics to help achieve earlier detection of melanoma.